Pharmacy Board of Australia v Chung

Link copied
Case Copied 12 min read
CITATION: Pharmacy Board of Australia v Chung [2012] QCAT 483
PARTIES: Pharmacy Board of Australia
v
Matthew Man-Yiu Chung
APPLICATION NUMBER: OCR004-12
MATTER TYPE: Occupational regulation matters
HEARING DATE: On the papers 28 August 2012
HEARD AT: Brisbane
DECISION OF: Kerrie O'Callaghan, Acting Deputy President
Assisted by:
Pamela Mathers
Andrew Petrie
Allen Thomas
DELIVERED ON: 2 October 2012
DELIVERED AT: Brisbane
ORDERS MADE:

1.    Mr Chung is reprimanded.

2.    The details of Mr Chung’s reprimand be recorded on the Board’s register for twelve months from the date of this order.

3.    The following conditions be imposed on Mr Chung’s registration:

a.    Mr Chung is to complete 50 credits of continuing professional development (“CPD”) within 12 months of the date of this order:

                   i.    At least 5 credits in Domain 1 (Professional and Ethical Practice): and

                 ii.    At least 5 credits in Domain 2 (Communication, Collaboration and Self Management).

b.    Mr Chung must demonstrate the pharmacy is accredited and/or has current accreditation under the Quality Care Pharmacy Program (“QCPP”), or equivalent, within 12 months from the date of this order.

c.    Mr Chung must maintain a membership of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia for a period of 12 months from the date of this order.

d.    Mr Chung will provide the Board with evidence that he is a member of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia within 1 month of the date of this order.

e.    Mr Chung will participate in a mentoring program that includes the following:

                   i.    Monthly sessions of mentoring for a period of 12 months.

                 ii.    Mr Chung is to nominate a mentor for the approval of the Board.

                 iii.    The mentor is to be a registered pharmacist, of appropriate maturity and experience, who has experience in the operation of a QCPP or equivalent accredited pharmacy.

                 iv.    During the period of mentoring, Mr Chung and the mentor will meet on 4 separate occasions at Mr Chung’s pharmacy for the purposes of the monthly mentoring.  Mr Chung will authorise the mentor to provide a report in writing to the Board at the end of each quarter and at the end of the period of the mentoring.

f.     Mr Chung is to nominate a mentor for the approval of the Board within 2 months of the date of this order.

g.    Mr Chung must bear the cost incurred to comply with these conditions.

h.    The details of the conditions imposed on Mr Chung’s registration be recorded on the Board’s register for the period in which the conditions are in force.

4.    Mr Chung not apply to the Chief Executive, Queensland Health, under the Health (Drugs and Poisons) Regulation 1996 (Qld) for reinstatement of his unrestricted endorsement under s 171 and s 257 of the regulation for pseudoephedrine for a period of 12 months from the date of this order.

5.    Pursuant to s 255 of the Act Mr Chung pay the Board’s costs of and incidental to these…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Pharmacy Board of Australia v Chung and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2012] QCAT 483
Decision Date

CaseChat Overview and Summary

In the matter of the Pharmacy Board of Australia, the appellant, and Mr Chung, the respondent, the Administrative Appeals Tribunal was tasked with examining whether the state or national scheme applied to the disciplinary proceedings against Mr Chung for his professional conduct as a pharmacist. The respondent, Mr Chung, a pharmacist in a rural town, was accused of failing to comply with the regulatory requirements for recording sales of pseudoephedrine and dispensing clomiphene on a general practitioner's prescription. The tribunal had to determine whether Mr Chung's conduct amounted to unsatisfactory professional conduct, especially considering the notorious use of pseudoephedrine for the illicit manufacture of methyl amphetamine and Mr Chung's professed ignorance of the regulatory requirements.

The tribunal considered whether the national or state scheme applied to the disciplinary proceedings against Mr Chung. Given that the Board had the power to take disciplinary action under the national scheme, the tribunal found that the national scheme applied. The tribunal also found that Mr Chung's conduct amounted to unsatisfactory professional conduct, as he failed to comply with the regulatory requirements for recording sales of pseudoephedrine, which was notorious for its use in the illicit manufacture of methyl amphetamine. The tribunal considered that Mr Chung's professed ignorance of the regulatory requirements did not excuse his failure to comply with them.

Based on its findings, the tribunal imposed several conditions on Mr Chung's registration, including completing 50 credits of continuing professional development, demonstrating that the pharmacy is accredited under the Quality Care Pharmacy Program, maintaining membership of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia, participating in a mentoring program, and refraining from applying for reinstatement of his unrestricted endorsement under the Health (Drugs and Poisons) Regulation 1996 (Qld) for pseudoephedrine for a period of 12 months. Mr Chung was also ordered to bear the cost incurred to comply with these conditions and pay the Board's costs of and incidental to these proceedings. The details of Mr Chung's reprimand and the conditions imposed on his registration were to be recorded on the Board's register for the relevant periods.

Orders

Orders of the court

1. Mr Chung is reprimanded.

2. The details of Mr Chung’s reprimand be recorded on the Board’s register for twelve months from the date of this order.

3. The following conditions be imposed on Mr Chung’s registration:

a. Mr Chung is to complete 50 credits of continuing professional development (“CPD”) within 12 months of the date of this order:

i. At least 5 credits in Domain 1 (Professional and Ethical Practice): and

ii. At least 5 credits in Domain 2 (Communication, Collaboration and Self Management).

b. Mr Chung must demonstrate the pharmacy is accredited and/or has current accreditation under the Quality Care Pharmacy Program (“QCPP”), or equivalent, within 12 months from the date of this order.

c. Mr Chung must maintain a membership of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia for a period of 12 months from the date of this order.

d. Mr Chung will provide the Board with evidence that he is a member of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia within 1 month of the date of this order.

e. Mr Chung will participate in a mentoring program that includes the following:

i. Monthly sessions of mentoring for a period of 12 months.

ii. Mr Chung is to nominate a mentor for the approval of the Board.

iii. The mentor is to be a registered pharmacist, of appropriate maturity and experience, who has experience in the operation of a QCPP or equivalent accredited pharmacy.

iv. During the period of mentoring, Mr Chung and the mentor will meet on 4 separate occasions at Mr Chung’s pharmacy for the purposes of the monthly mentoring. Mr Chung will authorise the mentor to provide a report in writing to the Board at the end of each quarter and at the end of the period of the mentoring.

f. Mr Chung is to nominate a mentor for the approval of the Board within 2 months of the date of this order.

g. Mr Chung must bear the cost incurred to comply with these conditions.

h. The details of the conditions imposed on Mr Chung’s registration be recorded on the Board’s register for the period in which the conditions are in force.

4. Mr Chung not apply to the Chief Executive, Queensland Health, under the Health (Drugs and Poisons) Regulation 1996 (Qld) for reinstatement of his unrestricted endorsement under s 171 and s 257 of the regulation for pseudoephedrine for a period of 12 months from the date of this order.

5. Pursuant to s 255 of the Act Mr Chung pay the Board’s costs of and incidental to these proceedings in the sum that is agreed or assessed.